We are not surprised by these findings. In fact, these results provide further evidence consistent with the Theory of Microcompetition proposed by Dr. Hanan Polansky. - Greg Bennett, CBCD
Rochester, NY (PRWEB) August 26, 2013
HCMV DNA and proteins have been found in breast cancer tumors according to two new studies. Recently, Mexican researchers confirmed that HCMV DNA was found in breast cancer tumors (1). Another study published in PLoS One on February 22, 2013 showed the presence of HCMV proteins in breast cancer tumors. (2)
The CBCD's Greg Bennett said, “We are not surprised by these findings. In fact, these results provide further evidence consistent with the Theory of Microcompetition proposed by Dr. Hanan Polansky and discussed in his ground breaking book, ‘Microcompetition with Foreign DNA and the Origin of Chronic Disease.’ We’ve long believed that latent viruses like HCMV are the underlying cause of many major diseases.”
Greg Bennett further noted, “In the nucleus, "microcompetition" between the foreign N-boxes and the human N-boxes in the human genes can lead to a major disease. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent (dormant) or the viral DNA is broken into pieces and cannot express proteins. As predicted by Dr. Hanan Polansky, many studies found fragments of DNA that belong to these viruses in tumors, clogged arteries (arterial plaque), arthritic joints, and other diseased tissues.”
According to Cancer.org in a page last updated on August 23, 2012, “Breast cancer is the most common cancer among American women, except for skin cancers. About 1 in 8 (12%) women in the US will develop invasive breast cancer during their lifetime.
The American Cancer Society's estimates for breast cancer in the United States are for 2013:
- About 232,340 new cases of invasive breast cancer will be diagnosed in women.
- About 64,640 new cases of carcinoma in situ (CIS) will be diagnosed (CIS is non-invasive and is the earliest form of breast cancer).
- About 39,620 women will die from breast cancer (3).”
The CBCD is pleased that there is more evidence that supports the Theory of Microcompetition. According to the website for the National Institute for Health (NIH), “The NIH invests over $30.9* billion annually in medical research for the American people. (4).” Cancer.gov reveals that the current budget for the National Cancer Institute (NCI) which is a division of the NIH is $4.78 billion (5).
The CBCD suggests that perhaps it is time for the NCI to open up a Program Project Grant (PO1) to facilitate further, broad research into Microcompetition with Foreign DNA. We believe that such a program can generate a breakthrough in cancer research that everyone is yearning for.
The CBCD invites doctors, biologists, virologists and other medical professionals to learn more about the Theory of Microcompetition by downloading Dr. Polansky’s book for free at: http://www.cbcd.net .
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.